KB195
/ Kaleido Biosci
- LARVOL DELTA
Home
Next
Prev
1 to 3
Of
3
Go to page
1
October 26, 2020
A Clinical Study to Assess the Effect of Novel Glycans on Nitrogen Metabolism of the Gut in Healthy Subjects
(clinicaltrials.gov)
- P=N/A; N=47; Completed; Sponsor: Kaleido Biosciences
Clinical • New trial
June 11, 2020
UNLOCKED: A Phase 2, Open-label Trial With KB195 in Subjects With a Urea Cycle Disorder
(clinicaltrials.gov)
- P2; N=24; Recruiting; Sponsor: Kaleido Biosciences; Trial completion date: Nov 2020 ➔ Nov 2021; Trial primary completion date: Oct 2020 ➔ Oct 2021
Clinical • Trial completion date • Trial primary completion date
March 12, 2020
UNLOCKED: A Phase 2, Open-label Trial With KB195 in Subjects With a Urea Cycle Disorder
(clinicaltrials.gov)
- P2; N=24; Recruiting; Sponsor: Kaleido Biosciences; Trial completion date: Jul 2020 ➔ Nov 2020; Trial primary completion date: Apr 2020 ➔ Oct 2020
Clinical • Trial completion date • Trial primary completion date
1 to 3
Of
3
Go to page
1